Yarrow Bioscience earnings were -$21.5M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest YARW earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$3.6M, down 25.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, YARW reported annual earnings of -$26.5M, with -33.5% growth. The next YARW earnings date is Aug 13, 2026.
What were Yarrow Bioscience's earnings last quarter?
Yarrow Bioscience (NASDAQ: YARW) reported Q1 2026 earnings per share (EPS) of -$4.00, up 60% year over year. Total YARW earnings for the quarter were -$3.59 million. In the same quarter last year, Yarrow Bioscience's earnings per share (EPS) was -$10.00.
The next YARW earnings date is Aug 13, 2026. Add YARW to your watchlist to be reminded of Yarrow Bioscience's next earnings date.
What was YARW's earnings growth in the past year?
As of Yarrow Bioscience's earnings date in Q3 2026, Yarrow Bioscience's earnings has grown year over year. YARW earnings in the past year totalled -$21.46 million.
Is Yarrow Bioscience profitable or losing money?
As of the last Yarrow Bioscience earnings report, Yarrow Bioscience is currently losing money. Yarrow Bioscience's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$21.46 million, a 49.15% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.